mRNA Platform

The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to develop the first mRNA-based prophylactic malaria vaccine. Supported by the World Health Organization (WHO), the Africa Centres for Disease Control and Prevention, the European Commission and European Investment Bank, and international partners, the project aims to use […]

...